BioWorld (@BioWorld): "Kasvu’s €30M series A to take novel #antidepressant into the clinic https://www.bioworld.com/articles/734296-kasvus-30m-series-a-to-take-novel-antidepressant-into-the-clinic #biopharma #financing" | nitter

BioWorld

@BioWorld

Sep 24

Kasvu’s €30M series A to take novel #antidepressant into the clinic bioworld.com/articles/734296… #biopharma #financing

Kasvu’s €30M series A to take novel antidepressant into the clinic

Finnish newco Kasvu Therapeutics has raised €30 million (US$34.4 million) in a series A financing to take forward novel small molecules that have the antidepressant benefits of psychedelic drugs, but...

Sep 24, 2026 · 8:06 PM UTC

3

544

Sort replies: Relevant Recent Liked